Homozygous stop mutation in AHR causes autosomal recessive foveal hypoplasia and infantile nystagmus.


Journal

Brain : a journal of neurology
ISSN: 1460-2156
Titre abrégé: Brain
Pays: England
ID NLM: 0372537

Informations de publication

Date de publication:
01 06 2019
Historique:
received: 27 07 2018
revised: 04 02 2019
accepted: 16 02 2019
pubmed: 23 4 2019
medline: 13 3 2020
entrez: 23 4 2019
Statut: ppublish

Résumé

Herein we present a consanguineous family with three children affected by foveal hypoplasia with infantile nystagmus, following an autosomal recessive mode of inheritance. The patients showed normal electroretinography responses, no signs of albinism, and no anterior segment or brain abnormalities. Upon whole exome sequencing, we identified a homozygous mutation (c.1861C>T;p.Q621*) in the aryl hydrocarbon receptor (AHR) gene that perfectly co-segregated with the disease in the larger family. AHR is a ligand-activated transcription factor that has been intensively studied in xenobiotic-induced toxicity. Further, it has been shown to play a physiological role under normal cellular conditions, such as in immunity, inflammatory response and neurogenesis. Notably, knockout of the Ahr gene in mouse impairs optic nerve myelin sheath formation and results in oculomotor deficits sharing many features with our patients: the eye movement disorder in Ahr-/- mice appears early in development and presents as conjugate horizontal pendular nystagmus. We therefore propose AHR to be a novel disease gene for a new, recessively inherited disorder in humans, characterized by infantile nystagmus and foveal hypoplasia.

Identifiants

pubmed: 31009037
pii: 5476095
doi: 10.1093/brain/awz098
pmc: PMC6766433
mid: EMS84047
doi:

Substances chimiques

AHR protein, human 0
Ahr protein, mouse 0
Basic Helix-Loop-Helix Transcription Factors 0
Receptors, Aryl Hydrocarbon 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1528-1534

Subventions

Organisme : Department of Health
ID : CL-2017-11-003
Pays : United Kingdom

Informations de copyright

© The Author(s) (2019). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Références

Am J Hum Genet. 1999 Apr;64(4):1141-6
pubmed: 10090899
J AAPOS. 1999 Apr;3(2):70-9
pubmed: 10221798
Hum Mol Genet. 1999;8(10):1893-900
pubmed: 10469842
J Biol Chem. 2001 Nov 9;276(45):42302-10
pubmed: 11551916
Science. 2001 Sep 21;293(5538):2256-9
pubmed: 11567139
J Med Genet. 2003 Jan;40(1):37-41
pubmed: 12525540
Eye (Lond). 2007 Sep;21(9):1194-7
pubmed: 16732211
Nat Genet. 2006 Nov;38(11):1242-4
pubmed: 17013395
Arch Ophthalmol. 2007 Sep;125(9):1255-63
pubmed: 17846367
Brain. 2008 May;131(Pt 5):1259-67
pubmed: 18372314
Invest Ophthalmol Vis Sci. 2009 Nov;50(11):5201-6
pubmed: 19458336
Eur J Hum Genet. 2010 May;18(5):544-52
pubmed: 20029458
Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10602-7
pubmed: 20498079
Brain. 2011 Mar;134(Pt 3):892-902
pubmed: 21303855
Ophthalmology. 2011 Aug;118(8):1653-60
pubmed: 21529956
Hum Genet. 2012 May;131(5):697-702
pubmed: 22065086
J Hum Genet. 2012 Dec;57(12):756-9
pubmed: 22914672
PLoS One. 2013;8(1):e53520
pubmed: 23301081
Am J Hum Genet. 2013 Dec 5;93(6):1143-50
pubmed: 24290379
Hum Mol Genet. 2014 Aug 1;23(15):4086-93
pubmed: 24688117
Pediatr Neonatol. 2014 Oct;55(5):341-51
pubmed: 25086850
Hum Mutat. 2015 Mar;36(3):379-87
pubmed: 25504618
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Neuron. 2016 Jan 6;89(1):177-93
pubmed: 26711119
Sci Rep. 2016 Aug 18;6:32009
pubmed: 27535013
Nature. 2016 Aug 17;536(7616):285-91
pubmed: 27535533
Eur J Hum Genet. 2017 Jun;25(6):725-734
pubmed: 28378818
Sci Rep. 2017 Aug 29;7(1):9794
pubmed: 28851966
Hum Mol Genet. 2018 Jul 15;27(14):2563-2572
pubmed: 29726989
Nat Genet. 1995 May;10(1):13-9
pubmed: 7647783
Nat Genet. 1996 Jun;13(2):141-2
pubmed: 8640214
Genomics. 1996 May 1;33(3):523-6
pubmed: 8661013
Mol Pharmacol. 1996 Sep;50(3):538-48
pubmed: 8794892
Invest Ophthalmol Vis Sci. 1997 Mar;38(3):767-73
pubmed: 9071231
Genomics. 1998 Nov 15;54(1):176-7
pubmed: 9806847

Auteurs

Anja K Mayer (AK)

Molecular Genetics Laboratory, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany.

Muhammad Mahajnah (M)

Child Neurology and Development Center, Hillel-Yaffe Medical Center, Hadera, Israel.
The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.

Mervyn G Thomas (MG)

Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.

Yuval Cohen (Y)

The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Ophthalmology Department, Hillel Yaffe Medical Center, Hadera, Israel.

Adib Habib (A)

Pediatric Department, St. Vincent French Hospital, Nazareth, Israel.

Martin Schulze (M)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.

Gail D E Maconachie (GDE)

Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.

Basamat AlMoallem (B)

Center for Medical Genetics Ghent, Ghent University and Ghent University Hospital, Ghent, Belgium.
Department of Ophthalmology, King Abdul-Aziz University Hospital, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Elfride De Baere (E)

Center for Medical Genetics Ghent, Ghent University and Ghent University Hospital, Ghent, Belgium.

Birgit Lorenz (B)

Department of Ophthalmology, Justus Liebig University Giessen, Giessen, Germany.

Elias I Traboulsi (EI)

Cole Eye Institute, Cleveland, Ohio, USA.

Susanne Kohl (S)

Molecular Genetics Laboratory, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany.

Abdussalam Azem (A)

Department of Biochemistry and Molecular Biology, Tel Aviv University, Tel Aviv, Israel.

Peter Bauer (P)

Institute of Medical Genetics and Applied Genomics, University of Tuebingen, Tuebingen, Germany.

Irene Gottlob (I)

Ulverscroft Eye Unit, Department of Neuroscience, Psychology and Behaviour, University of Leicester, Leicester, UK.

Rajech Sharkia (R)

The Triangle Regional Research and Development Center, Kfar Qari', Israel.
Beit-Berl Academic College, Beit-Berl, Israel.

Bernd Wissinger (B)

Molecular Genetics Laboratory, Institute for Ophthalmic Research, University of Tuebingen, Tuebingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH